Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

NCT05139121 is registered in ClinicalTrials.gov with Mylan Technologies Inc. as lead sponsor.

NCT NCT05139121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety
Lead sponsor
Mylan Technologies Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 26, 2021
Completion date
January 15, 2025
Enrollment
1,320 (actual)
Sites
100

Conditions

As the registry lists them; a condition with its own page is linked.

contraception